User profiles for D. van Baarle

Debbie van baarle

Verified email at rivm.nl
Cited by 10776

[HTML][HTML] T cell responses to viral infections–opportunities for peptide vaccination

…, J de Jonge, W Luytjes, D van Baarle - Frontiers in …, 2014 - frontiersin.org
An effective immune response against viral infections depends on the activation of cytotoxic
T cells that can clear infection by killing virus-infected cells. Proper activation of these T cells …

Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review

…, R Eilers, HE de Melker, D van Baarle - Experimental …, 2016 - Elsevier
… Supplementary file D provides an overview of the outcomes from the quality/risk of bias-…
More detailed features of the studies and their limitations are stated in Supplementary file D. …

[HTML][HTML] Immune activation and collateral damage in AIDS pathogenesis

…, MD Hazenberg, K Tesselaar, D van Baarle… - Frontiers in …, 2013 - frontiersin.org
In the past decade, evidence has accumulated that human immunodeficiency virus (HIV)-induced
chronic immune activation drives progression to AIDS. Studies among different …

[HTML][HTML] Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming

…, M Lafeber, D van Baarle… - … England Journal of …, 2022 - Mass Medical Soc
Background The Ad26.COV2.S vaccine, which was approved as a single-shot immunization
regimen, has been shown to be effective against severe coronavirus disease 2019. …

VDJdb: a curated database of T-cell receptor sequences with known antigen specificity

…, DC Douek, F Luciani, D Van Baarle… - Nucleic acids …, 2018 - academic.oup.com
The ability to decode antigen specificities encapsulated in the sequences of rearranged T-cell
receptor (TCR) genes is critical for our understanding of the adaptive immune system and …

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …

…, CACM van Els, NY Rots, D van Baarle… - The Lancet …, 2021 - thelancet.com
… Therefore, to test for non-inferiority, we decided that the anticipated true response rates in
cohorts B, C, and D all had to be equal to the observed true response rate in cohort A (ie, 100%…

[HTML][HTML] Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life

M Reyman, MA van Houten, D van Baarle… - Nature …, 2019 - nature.com
The early-life microbiome appears to be affected by mode of delivery, but this effect may
depend on intrapartum antibiotic exposure. Here, we assess the effect of delivery mode on gut …

γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia

…, C Donner, B Plachter, D Vermijlen, D van Baarle… - Leukemia, 2013 - nature.com
… (d) The majority of CD8 on γδT cells of congenitally infected newborns is composed of
the CD8αα homodimer. Percentages of CD8+ γδT cells and CD8+ αβT cells … D van Baarle

[HTML][HTML] The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on …

…, CC Baan, D van Baarle, R van Binnendijk… - …, 2022 - journals.lww.com
Background. In kidney patients COVID-19 is associated with severely increased morbidity
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …

[HTML][HTML] Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA …

…, D van Baarle, R van Binnendijk… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …